Suchergebnisse - "Oriol, Albert"

PubPharm (383)

1

Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma

enthalten in: Cancer | 2024

von Suvannasankha, A. | Bahlis, N. | Trudel, S. | +17

2

An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd) : SELECT study

enthalten in: Leukemia & lymphoma | 2024

von Perrot, A. | Delimpasi, S. | Spanoudakis, E. | +8

3

Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma : Results From the Phase II MajesTEC-1 Study

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Martin, T. | Moreau, P. | Usmani, S. | +20

4

Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma : A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Oriol, A. | Dimopoulos, M. | Schjesvold, F. | +12

5

ANCHOR : melflufen plus dexamethasone and daratumumab or bortezomib in relapsed/refractory multiple myeloma: final results of a phase I/IIa study

enthalten in: Haematologica | 2024

von Ocio, E. | Efebera, Y. | Hájek, R. | +12

6

Promises, Pitfalls, and Clinical Applications of Artificial Intelligence in Pediatrics

enthalten in: Journal of medical Internet research | 2024

von Bhargava, H. | Salomon, C. | Suresh, S. | +7

7

Predictors of unsustained measurable residual disease negativity in transplant-eligible patients with multiple myeloma

enthalten in: Blood | 2024

von Guerrero, C. | Puig, N. | Cedena, M. | +20

CommentIn: Blood. 2024 Feb 15;143(7):564-566. - PMID 38358852

8

Selinexor, daratumumab, bortezomib and dexamethasone for the treatment of patients with relapsed or refractory multiple myeloma : results of the phase II, non-randomized, multicenter GEM-SELIBORDARA study

enthalten in: Haematologica | 2024

von González-Calle, V. | Rodríguez-Otero, P. | Sureda, A. | +17

9

CD200 genotype is associated with clinical outcome of patients with multiple myeloma

enthalten in: Frontiers in immunology | 2024

von Gonzalez-Montes, Y. | Osca-Gelis, G. | Rodriguez-Romanos, R. | +13

10

Recovery of uninvolved heavy/light chain pair immunoparesis in newly diagnosed transplant-eligible myeloma patients complements the prognostic value of minimal residual disease detection

enthalten in: Haematologica | 2023

von Lakhwani, S. | Rosiñol, L. | Puig, N. | +30

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[39]